Citation Impact
Citing Papers
Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM
2007
A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis
2014
Benchmarking the stability of human detergent-solubilised voltage-gated sodium channels for structural studies using eel as a reference
2015 StandoutNobel
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
Astrocytes: biology and pathology
2009 Standout
Human conditions of insulin-like growth factor-I (IGF-I) deficiency
2012
Sporadic inclusion body myositis—diagnosis, pathogenesis and therapeutic strategies
2006
Value of the Oral Glucose Tolerance Test in the Evaluation of Chronic Idiopathic Axonal Polyneuropathy
2006
Friedreich‐like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the α‐Tocopherol transfer protein gene
1997
Diagnosis of amyotrophic lateral sclerosis
1998
Differential gene expression of cytokines and neurotrophic factors in nerve and skin of patients with peripheral neuropathies
2014
Acute motor axonal neuropathy: An antibody‐mediated attack on axolemma
1996
Inclusion body myositis and myopathies
1995 Standout
Hyperreflexia in axonal Guillain–Barré syndrome subsequent to Campylobacter jejuni enteritis
2002
Myasthenia Gravis
2016 Standout
Loss of electrical excitability in an animal model of acute quadriplegic myopathy
1998
Long-term observational study of sporadic inclusion body myositis
2011
Painful sensory polyneuropathy associated with impaired glucose tolerance
2001
The value of skin biopsy with recording of intraepidermal nerve fiber density and quantitative sensory testing in the assessment of small fiber involvement in patients with different causes of polyneuropathy
2009
Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits
2000
Advances in Positive Airway Pressure Treatment Modalities for Hypoventilation Syndromes
2014
The effect of body position on pulmonary function: a systematic review
2018
Glutamate uptake
2001 Standout
Guillain–Barré and Miller Fisher syndromes—new diagnostic classification
2014
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome
1996
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
The unfolded protein response: controlling cell fate decisions under ER stress and beyond
2012 Standout
Guillain-Barré syndrome
2016 Standout
One-Year Outcomes in Survivors of the Acute Respiratory Distress Syndrome
2003 Standout
Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges
2010 Standout
Botulinum Toxin as a Biological Weapon
2001 Standout
MUSCLE DYSFUNCTION IN THE INTENSIVE CARE UNIT
1999
Amyotrophic lateral sclerosis
2017
Design and development of polymers for gene delivery
2005 Standout
Guillain–Barré Syndrome
2012 Standout
Triptans in Migraine
2000
Amyotrophic lateral sclerosis
2011 Standout
Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes
2011
Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects
2003
Sepsis and the systemic inflammatory response syndrome
1996
Severe Sepsis and Septic Shock
2013 Standout
Causes of neuromuscular weakness in the intensive care unit: A study of ninety-two patients
1998
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
Comparative analysis of therapeutic options used for myasthenia gravis
2010
Inclusion body myositis
2002
Retinitis pigmentosa
2006 Standout
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Prolonged weakness after cisatracurium infusion
1998
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Dextromethorphan/Quinidine: A Review of Its Use in Adults with Pseudobulbar Affect
2014
Neuromuscular Sequelae in Survivors of Acute Lung Injury
2006
Graft-versus-host disease
2009 Standout
Inherited disorders of voltage-gated sodium channels
2005
The Diagnostic Yield of a Standardized Approach to Idiopathic Sensory-Predominant Neuropathy
2004
Myasthenia gravis: past, present, and future
2006
Alzheimer's disease
2016 Standout
Inclusion body myositis
2007
Functional Disability 5 Years after Acute Respiratory Distress Syndrome
2011 Standout
The nonsystemic vasculitic neuropathies
2017
Use of human intravenous immunoglobulin in lower motor neuron syndromes
1999
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
2002 Standout
Hyperreflexia in Guillain-Barre syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody
1999
Botulism
2000
Phase II trial of methotrexate in myasthenia gravis
2012
IgG4-related disease
2014 Standout
Idiopathic polyneuropathy and impaired glucose metabolism in a Norwegian patient series
2008
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy
2008
Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features
2007
Non-systemic vasculitic neuropathy: single-center follow-up of 60 patients
2015
Striational Antibodies in Myasthenia Gravis
2005
Acquired immune and inflammatory myopathies
2011
Intracellular amyloid-β in Alzheimer's disease
2007 Standout
Polymyositis and dermatomyositis
2003 Standout
Central motor conduction time in patients with multifocal motor conduction block
1999
Six important themes in amyotrophic lateral sclerosis (ALS) research, 1999
2000
The familial periodic paralyses and nondystrophic myotonias
1998
Prediabetes: a high-risk state for diabetes development
2012 Standout
Amyotrophic Lateral Sclerosis
2001 Standout
Excitotoxic motoneuron disease in chick embryo evolves with autophagic neurodegeneration and deregulation of neuromuscular innervation
2007
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Intensive Insulin Therapy in Critically Ill Patients
2001 Standout
Guillain-Barré syndrome
2005 Standout
Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches
2007
Idiopathic Inflammatory Myopathies: Current Trends in Pathogenesis, Clinical Features, and Up-to-Date Treatment Recommendations
2012
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Advances in understanding and treatment of immune‐mediated disorders of the peripheral nervous system
2004
Myasthenia Gravis and its Animal Model: T Cell Receptor Expression in an Antibody Mediated Autoimmune Disease
1999
Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome
2010 Standout
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement
2019 Standout
Gene Therapy for Amyotrophic Lateral Sclerosis and Other Motor Neuron Diseases
2000
Amyotrophic Lateral Sclerosis Pathogenesis: A Journey Through the Secretory Pathway
2010
Increased Prevalence of Impaired Glucose Tolerance in Patients With Painful Sensory Neuropathy
2001
Inactivation defects caused by myotonia-associated mutations in the sodium channel III-IV linker.
1996
Cytosolic 5′‐nucleotidase 1A autoimmunity in sporadic inclusion body myositis
2012
Inflammatory Muscle Diseases
2015 Standout
The Mechanism of Vagal Stimulation of Gastric Acid Secretion
1955
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Plasma Gastrin and Gastric Acid Responses to Sham Feeding and Feeding in Dogs
1972 StandoutNobel
MOD-1 is a serotonin-gated chloride channel that modulates locomotory behaviour in C. elegans
2000 StandoutNatureNobel
Intravenous Immunoglobulin: Striving for Appropriate Use
2006
Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls
2000
Case 16-1999
1999
Guidelines for the Primary Prevention of Stroke
2014 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Neural Science
2000 StandoutNobel
Intravenous immunoglobulin for myasthenia gravis
2012
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment
2000
Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient
2002
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
β 2 -Glycoprotein 1–Dependent Anticardiolipin Antibodies and Risk of Ischemic Stroke and Myocardial Infarction
2001
Comparison of IVIg and PLEX in patients with myasthenia gravis
2011
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
The Emergence of Modern Neuroscience: Some Implications for Neurology and Psychiatry
2000 StandoutNobel
Pharmacologic treatment of pain in polyneuropathy
2000
Differential expression of cytokines in painful and painless neuropathies
2007
Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient
2016
Sensory profiles and skin innervation of patients with painful and painless neuropathies
2018
Twenty-four–Hour Blood Pressure and MRI as Predictive Factors for Different Outcomes in Patients With Lacunar Infarct
2002
Works of Carlayne E. Jackson being referenced
Acute Paralytic Syndrome in Three American Men
1993
Amyotrophic Lateral Sclerosis
1998
Inclusion body myositis functional rating scale: A reliable and valid measure of disease severity
2008
Inclusion body myositis: Clinical and pathological boundaries
1996
Paramyotonia congenita: Abnormal short exercise test, and improvement after mexiletine therapy
1994
Isolated vitamin E deficiency
1996
Creatine monohydrate in ALS: Effects on strength, fatigue, respiratory status and ALSFRS
2008
Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids
1994
Evaluation of Myosin-Reactive Antibodies from a Panel of Myasthenia Gravis Patients
1994
Electrophysiologic findings in multifocal motor neuropathy
1997
Open-Label Trial of Recombinant Human Insulin-like Growth Factor 1/Recombinant Human Insulin-like Growth Factor Binding Protein 3 in Myotonic Dystrophy Type 1
2010
Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis
2002
Chronic Cryptogenic Sensory Polyneuropathy
1999
Motor neuron disease.
2001
Distal myasthenia gravis
1999
Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy
2000
Primary hyperparathyroidism and ALS
1998
Motor Neuron Disease
2001
Inclusion body myositis
1994
Stimulation of Cell-Free Gastric Mucus by the Topical Application of Acetylcholine.
1951
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review)
2009 Standout
Model for the neuromuscular complications of systemic lupus erythematosus
1995
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review)
2009